74(top 1%)
papers
4.7K(top 1%)
citations
37(top 1%)
h-index
66(top 1%)
g-index
74
all documents
4.9K
doc citations
1.2K
citing journals

Top Articles

#TitleJournalYearCitations
1Activation of canonical Wnt signalling is required for TGF-β-mediated fibrosisNature Communications2012649
2Treg cells suppress osteoclast formation: A new link between the immune system and boneArthritis and Rheumatism2007317
312/15-Lipoxygenase Orchestrates the Clearance of Apoptotic Cells and Maintains Immunologic ToleranceImmunity2012204
4Blockade of Dickkopf (DKK)-1 induces fusion of sacroiliac jointsAnnals of the Rheumatic Diseases2010198
5Neutralisation of Dkk-1 protects from systemic bone loss during inflammation and reduces sclerostin expressionAnnals of the Rheumatic Diseases2010183
6Dual inhibition of c‐abl and PDGF receptor signaling by dasatinib and nilotinib for the treatment of dermal fibrosisFASEB Journal2008179
7IgG4 immune response in Churg–Strauss syndromeAnnals of the Rheumatic Diseases2012171
8Nintedanib inhibits fibroblast activation and ameliorates fibrosis in preclinical models of systemic sclerosisAnnals of the Rheumatic Diseases2016154
9Nintedanib inhibits macrophage activation and ameliorates vascular and fibrotic manifestations in the Fra2 mouse model of systemic sclerosisAnnals of the Rheumatic Diseases2017149
10Pathways for Bone Loss in Inflammatory DiseaseCurrent Osteoporosis Reports2012148
1112/15-Lipoxygenase Counteracts Inflammation and Tissue Damage in ArthritisJournal of Immunology2009138
12Churg–Strauss Syndrome in Childhood: A Systematic Literature Review and Clinical Comparison with Adult PatientsSeminars in Arthritis and Rheumatism2009124
13A comparative study of periarticular bone lesions in rheumatoid arthritis and psoriatic arthritisAnnals of the Rheumatic Diseases2011121
14Src kinases in systemic sclerosis: Central roles in fibroblast activation and in skin fibrosisArthritis and Rheumatism2008111
15Osteoimmunology in rheumatic diseasesArthritis Research and Therapy2009100
16Hypoxia. Hypoxia in the pathogenesis of systemic sclerosisArthritis Research and Therapy200999
17Eotaxin-3 is involved in Churg-Strauss syndrome - a serum marker closely correlating with disease activityRheumatology200898
18Inhibition of H3K27 histone trimethylation activates fibroblasts and induces fibrosisAnnals of the Rheumatic Diseases201393
19Stimulation of the soluble guanylate cyclase (sGC) inhibits fibrosis by blocking non-canonical TGFβ signallingAnnals of the Rheumatic Diseases201592
20Tumour necrosis factor blockade increases lymphangiogenesis in murine and human arthritic jointsAnnals of the Rheumatic Diseases200883
21Eotaxin-3 in Churg-Strauss syndrome: a clinical and immunogenetic studyRheumatology201178
22Heat shock protein 90 (Hsp90) inhibition targets canonical TGF-β signalling to prevent fibrosisAnnals of the Rheumatic Diseases201478
23Tophus resolution with pegloticase: a prospective dual-energy CT studyRMD Open201571
24Monocyte chemoattractant proteins in the pathogenesis of systemic sclerosisRheumatology200970
25Inactivation of tankyrases reduces experimental fibrosis by inhibiting canonical Wnt signallingAnnals of the Rheumatic Diseases201369
2612/15-Lipoxygenase during the regulation of inflammation, immunity, and self-toleranceJournal of Molecular Medicine201263
27A synthetic PPAR-γ agonist triterpenoid ameliorates experimental fibrosis: PPAR-γ-independent suppression of fibrotic responsesAnnals of the Rheumatic Diseases201462
28High frequency of autoantibody‐secreting cells and long‐lived plasma cells within inflamed kidneys of NZB/W F1 lupus miceEuropean Journal of Immunology201159
29Anti-inflammatory and cartilage-protecting effects of an intra-articularly injected anti-TNFα single-chain Fv antibody (ESBA105) designed for local therapeutic useAnnals of the Rheumatic Diseases201057
30Synovial immunopathology in haemochromatosis arthropathyAnnals of the Rheumatic Diseases201055
31Why does the gout attack stop? A roadmap for the immune pathogenesis of goutRMD Open201553
32High incidence of disease recurrence after discontinuation of disease-modifying antirheumatic drug treatment in patients with psoriatic arthritis in remissionAnnals of the Rheumatic Diseases201549
33Inhibition of casein kinase II reduces TGFβ induced fibroblast activation and ameliorates experimental fibrosisAnnals of the Rheumatic Diseases201545
34Effects of DMARDs on citrullinated peptide autoantibody levels in RA patients—A longitudinal analysisSeminars in Arthritis and Rheumatism201745
35Anti IL‐17A therapy inhibits bone loss in TNF‐α‐mediated murine arthritis by modulation of the T‐cell balanceEuropean Journal of Immunology201242
36Tyrosine Kinase Inhibitors in the Treatment of Systemic Sclerosis: From Animal Models to Clinical TrialsCurrent Rheumatology Reports201141
37Joint remodelling in inflammatory diseaseAnnals of the Rheumatic Diseases200738
38Measuring Pain and Efficacy of Pain Treatment in Inflammatory Arthritis: A Systematic Literature ReviewJournal of rheumatology Supplement, The201237
39Structural Bone Changes in pondyloarthritis: Mechanisms Clinical Impact and Therapeutic ConsiderationsAmerican Journal of the Medical Sciences201133
40Pathophysiology of SpondyloarthritisCurrent Rheumatology Reports201132
41Pomalidomide is effective for prevention and treatment of experimental skin fibrosisAnnals of the Rheumatic Diseases201231
42EUSTAR biobanking: recommendations for the collection, storage and distribution of biospecimens in scleroderma researchAnnals of the Rheumatic Diseases201130
43Targeting of NADPH oxidase in vitro and in vivo suppresses fibroblast activation and experimental skin fibrosisExperimental Dermatology201730
44Activation of liver X receptors inhibits experimental fibrosis by interfering with interleukin-6 release from macrophagesAnnals of the Rheumatic Diseases201528
45There is a need for new systemic sclerosis subset criteria. A content analytic approachScandinavian Journal of Rheumatology201828
46Novel targets in bone and cartilageBest Practice and Research in Clinical Rheumatology201027
47Inactivation of evenness interrupted (EVI) reduces experimental fibrosis by combined inhibition of canonical and non-canonical Wnt signallingAnnals of the Rheumatic Diseases201426
48Idiopathic hand osteoarthritis vs haemochromatosis arthropathy--a clinical, functional and radiographic studyRheumatology201325
49Morphogen Pathways in Systemic SclerosisCurrent Rheumatology Reports201323
50Multilayered drug delivery coatings composed of daidzein-loaded PHBV microspheres embedded in a biodegradable polymer matrix by electrophoretic depositionJournal of Materials Chemistry B201620